Jasper Therapeutics Inc. (JSPR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Jasper Therapeutics Inc. (JSPR:NASDAQ), powered by AI.

Current Price
$0.53
Sector
Healthcare
What is the Jasper Therapeutics Inc. stock price forecast?

Jasper Therapeutics Inc. is currently trading at $0.53. View real-time AI analysis on Alpha Lenz.

What is Jasper Therapeutics Inc. insider trading activity?

View the latest insider trading data for Jasper Therapeutics Inc. on Alpha Lenz.

What is Jasper Therapeutics Inc.'s P/E ratio?

View Jasper Therapeutics Inc.'s valuation metrics on Alpha Lenz.

Jasper Therapeutics Inc.

NASDAQ · JSPR
$0.53-0.29(-35.56%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Jasper Therapeutics Inc.'s future dividend policy...
Alpha Chat Insight

Jasper Therapeutics Inc.'s ROE is -230.3%. Explore profitability and growth together.

Ask for details

Company Overview

Jasper Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for disease treatment, particularly in the field of hematopoietic cell transplantation, autoimmune diseases, and chronic immune disorders. The company's approach relies on targeted technologies aimed at improving the safety and effectiveness of blood and immune system replacement therapies. This is critical in medical procedures like bone marrow transplants where the treatment preconditioning traditionally includes high-dose chemotherapy or radiation, posing significant risks to patients. Jasper Therapeutics strives to provide safer and more effective alternatives, thereby offering a potentially transformative impact on patient outcomes in these sectors. As an entity within the biotechnology industry, its developments have significant implications for healthcare advancements and patient care methodologies. Jasper Therapeutics is strategically positioned within the biotech market, making substantial contributions through its research and development efforts towards better treatment paradigms in its niche areas.

CEOMr. Ronald A. Martell
SectorHealthcare
IndustryBiotechnology
Employees64

Company Statistics

FY 2025

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
64Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-131.06%ROA
-230.31%ROE
-145.03%ROIC

Financial Health

$28.69MCash & Cash Equivalents
$2.94MNet Debt
761.94%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Jasper Therapeutics Inc. (ticker: JSPR) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 64 employees.

The current price is $0.534 with a P/E ratio of -x and P/B of -x.

ROE is -230.31%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Jasper Therapeutics Inc. (JSPR) Stock Forecast 2026 $0.53 — Price, Financials & Analyst Targets | Alpha Lenz